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Summary
Introduction: Basic ﬁbroblast growth factor (FGF2) is a mitogen for articular chondrocytes. Cell death frequently occurs upon cartilage wound-
ing and is evident during the progression of osteoarthritis. We hypothesised that incubation of wounded articular cartilage with exogenously
added FGF2 would enhance cartilage repair, replacing dead cells through increased cell proliferation.
Methods: Articular cartilage from the metacarapalphalangeal joint of immature bovine steers was wounded in situ, then incubated in vitro in the
continual presence or absence of FGF2. Cellular proliferation was expressed as a ratio of cell density of a ﬁxed area between wounded and
adjacent cartilage. Immunolabelling revealed the incorporation of bromodeoxyuridine and localisation of collagen type VI and Notch1 epitopes.
g-secretase inhibitor N-[N-(3,5-Diﬂuorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester and soluble Jagged1 ligand (sJ1) were used to
analyse the function of Notch signalling in this wound model.
Results: FGF2 induced cellular proliferation at the margins of wounded articular cartilage, where proliferative chondrocytes adopted a cluster
conﬁguration. Collagen type VI protein was expressed by chondrocytes in clusters, as was Notch1. Cellular proliferation was not affected by
inhibition of g-secretase dependent Notch1 signalling. Binding of sJ1 to Notch1 receptors in FGF2 treated cartilage inhibited proliferation.
Conclusion: Addition of FGF2 induces rapid chondrocyte proliferation in wounded cartilage, chondrocytes adopt a cluster morphology and
also express Notch1. Binding of sJ1 to Notch1 causes apoptosis overriding a proliferative response. This study may shed some light on
the signiﬁcance of increased Notch1 expression and its localisation in chondrocyte clusters in osteoarthritic cartilage.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction enters the nucleus and phosphorylates and activates tran-Fibroblast growth factor (FGF) is a family of at least 24
growth-regulatory that have potent mitogenic effects on
a variety of cells of mesodermal and ectodermal origin1.
Fibroblast growth factor-2, or basic ﬁbroblast growth factor
(FGF2) is synthesised by articular chondrocytes and co-lo-
calises with perlecan within the collagen type VI-rich peri-
cellular matrix2. FGF2 is sequestered within the
pericellular domain through interactions with the heparan
sulphate proteoglycan, perlecan, an interaction that can
be disrupted through the action of heparanases. Although
the speciﬁc mechanisms that activate receptor binding are
presently unknown, following ligand binding, receptor di-
merisation and autophosphorylation is induced stimulating
receptor tyrosine kinase activity and substrate interactions
within the intracellular domain. The most common intracel-
lular pathway activated through FGF2 receptor binding is
the MAPK pathway. Signalling cascades through phosphor-
ylation of a series of MAP kinases (Raf, MEK, ERK). ERK*Address correspondence and reprint requests to: C. W. Archer,
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208scription factor Elk-1 which then regulates it targets
genes3,4.
FGF2 is a potent mitogen for chondrocytes5, and in addi-
tion it has been demonstrated that FGF2 reduces dediffer-
entiation of monolayer expanded articular chondrocytes,
such that these cells can be subsequently redifferentiated
to form cartilage with greater efﬁciency6e8. FGF2 stimulates
the production of sox9 and this property may account for
a greater capacity for redifferentiation of articular chondro-
cytes following culture expansion9. Whilst FGF2 is mito-
genic it has also been known for many years that it does
not induce an anabolic response in articular chondrocytes
at least as characterised by synthesis of sulphated glycos-
aminoglycans (sGAG)5. FGF2 also inhibits insulin growth
factor-1 (IGF1) and OP1 inducible sulphate incorporation
in chondocytes10.
In the context of articular cartilage injury, FGF2 has been
shown to be important in many respects. Firstly, upon me-
chanical injury to cartilage FGF2 is released and activates
MAPK-dependent signalling11, and that secondly, FGF2 is
found at increased concentrations in synovial ﬂuid from pa-
tients with degenerative joint disease, the source of which
was found to be inﬂamed synovial tissue12. Our previous
studies have demonstrated that experimental wounding of
Fig. 1. FGF2 stimulates chondrocyte proliferation in wounded articular cartilage. FGF2 (100 ng/ml) was added exogenously to wounded ar-
ticular cartilage or left untreated, and then cultured for up to 21 days. The micrograph shows cluster formation at the wound edges of control
(arrows) and FGF2 treated (arrowheads) cartilage explant sections stained with haemotoxylin and eosin (A). Graph depicting the increase in
cell density, as a ratio of cells counted in a ﬁxed area (400 mm 300 mm) in the wound region and an adjacent region, of explants grown in the
absence or presence of 1 ng/ml, 10 ng/ml or 100 ng/ml FGF2 for 10.5 or 21 days (n¼ 6; P< 0.05) (B). The FGFR inhibitor PD173074 inhibits
exogenous FGF2 induced cellular proliferation in explants (n¼ 4, P< 0.05) (C). Bar equals 50 mm.
209Osteoarthritis and Cartilage Vol. 18, No. 2articular cartilage initially induces the appearance of a zone
of necrosis and apoptosis at the wound margin and that af-
ter 14 days a proliferative response is evident in surviving
chondrocytes surrounding the wound margin13. Ampliﬁca-
tion of the reparative proliferative response would be desir-
able as cell death strongly correlates with a reduced
capacity to maintain the surrounding extracellular matrix,leading to matrix degeneration over time14. Therefore, we
hypothesised that exogenous application of FGF2 to
wounded articular cartilage would enhance an intrinsic pro-
liferative reparative response; cell counts were made to de-
termine if this was the case and histologic analysis was
performed to analyse the morphology and distribution of
chondrocytes at the wound edge. Our earlier studies have
Fig. 2. Quantitative analysis of number of chondrocytes per lacunae in wounded explants cultured in the presence or absence of FGF2 for 21
days. The graph shows the frequency of chondrocytes occupying a single lacunae within a ﬁxed area (600 mm 200 mm) at the wound edges
of control explants or explants treated with 1 ng/ml, 10 ng/ml or 100 ng/ml FGF2 for 21 days. Immunohistochemical detection of bromodeox-
yuridine incorporation in chondrocytes in S-phase at the wound edges of control (non-treated) or FGF treated (100 ng/ml) explants for 21 days
Bar equals 50 mm. (B). Arrowheads denote the location of positively staining nuclei. Magniﬁcation 2500. Cell count ratios of BrdU-positive
nuclei divided by the total number of cells per unit area in the wound edge and adjacent control regions of FGF treated and untreated explants,
(n¼ 3; P< 0.05) (C).
210 I. M. Khan et al.: FGF2 induces chondrocyte clusters in situshown that articular cartilage undergoes appositional
growth, and that the zone of growth corresponds with
bromodeoxyuridine incorporation and Notch1 proteinlocalisation in the surface zone15e17. Other studies have
shown that Notch1 expression levels are increased in
osteoarthritic (OA) cartilage18 and that Notch1 co-localises
Fig. 3. Immunolocalisation of collagen type VI in chondrocyte clusters. Chondrocyte clusters in FGF2 treated wounded immature bovine ex-
plants sections (A, C and E) and bovine OA cartilage sections (B, D and F) were either stained with haemotoxylin and eosin (A, B) or screened
with rabbit anti-collagen type VI (green) (C, D) or rabbit IgG (E, F). Anti-rabbit secondary antibody conjugated with FITC was used to reveal the
epitopes. Propidium iodide was used to ﬂuorescently stain nuclei. Bar equals 50 mm.
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Notch1 is re-expressed and potential signiﬁcance of Notch
signalling within cells at the wound edge was also explored.Materials and methodsTISSUEImmature articular cartilage was obtained from immature 7-day-old bovine
steers. The medial aspect of the medial groove of metacarpalphalangeal
joints were injured in situ using a 6 mm biopsy punch (Steifel) under sterile
conditions in a tissue culture hood. Full-depth 6 mm diameter discs of artic-
ular cartilage were aseptically harvested from the joint using a scalpel blade
to cut under the wound created using the biopsy punch. The explants were
cultured overnight in 24 well culture dishes at 37C in 5.0% CO2 to equilibri-
ate in 1.5 ml standard culture medium consisting of Dulbecco’s modiﬁed
Eagle’s medium (DMEM) and Ham’s F-12 (1:1) -glutamine nutrient mixture,
10% foetal calf serum, 50 mg/ml asborbate-2-phosphate (Sigma-Aldrich),10 mM HEPES pH 7.5, 100 mg/ml penicillin and 100 mg/ml streptomycin.
Treatment of explants began the following day. Explants used in experimen-
tal sets were taken from the same joint, and multiple experimental sets uti-
lised multiple joints.TREATMENT OF WOUNDED CARTILAGE EXPLANTSThe 6 mm diameter cores of wounded explants were either treated with in-
creasing concentrations (1, 10 or 100 ng/ml; changed three times per week) of
FGF2 (Peprotech) in standardmedium or with standardmedium alone. Explants
were removedat10.5 daysand21days to analyse cell proliferation. Todetermine
if proliferation was due to the action of endogenous and exogenously applied
FGF2 we used the FGF receptor inhibitor N-[2-[[4-(Diethylamino)butyl] amino-6-
(3,5-) pyrido[2,3-d]pyrimidin-7-yl]-N-(1,1-dimethylethyl)urea (PD173074; Sigma)
dissolved in dimethyl sulphoxide (DMSO) and used at a ﬁnal concentration of
250 nM20. The inhibitor was replenished with every culture medium change.
The g-secretase inhibitor 5-Diﬂuorophenylacetyl-L-alanyl-2-phenylglycine-1,1-di-
methylethyl ester (DAPT) was dissolved in 100% DMSO and added to the cul-
ture medium at a ﬁnal concentration of 100 mM in the presence or absence of
Fig. 4. Immunoﬂuorescent detection of Notch1 in FGF2 treated explant wound edges. Wounded explants cultured in the absence (A, C) or
presence of 100 ng/ml FGF2 (B, D) were screened with rat-anti Notch1 (bTAN20) antibody (A, B) or rat IgG (C, D). Anti-rat secondary anti-
bodies conjugated with FITC (green) were used to reveal antibody binding. Labelling for Notch1 was present in chondrocytes in FGF2 treated
wound sites (B; thick white arrows) and either absent or weakly labelled in untreated explants (A). Thin arrows denote the wound edge. Nuclei
were counterstained with propidium iodide. Bar equals 50 mm.
212 I. M. Khan et al.: FGF2 induces chondrocyte clusters in situFGF2and replenishedthriceweekly.Control explantsweresupplementedwithan
identical concentrationofDMSO.Explants treatedwithDAPTwerecultured for 21
days prior to analysis. Soluble Jagged1 (recombinant rat Fc chimera; R&D Sys-
tems) was used at a concentration of 100 ng/mL in the presence or absence of
FGF2 and replenished thrice weekly to 21 days.QUANTITATIVE ANALYSIS OF CELLULAR PROLIFERATIONFollowing culture, explants were ﬁxed overnight in 4% paraformaldehyde
at 4C, processed to wax and embedded. Tenmicron sections were stained
with Harris’ haematoxylin and eosin, or Safranin-O (60 s), and viewed using
a Leica DMRB light microscope in order to assess changes in cartilage archi-
tecture, chondrocyte morphology. To quantify changes in cell number at the
wound edge, chondrocytes within an area 400 mm 300 mm from the wound
edge and 300 mm from the surface were manually counted. Cell counts were
performed in the mid-region to avoid the superﬁcial zone where cell death is
greatest upon wounding13. A 400 mm 300 mm area immediately and later-
ally adjacent to the initial area was used to generate cell counts for compar-
ison. The data from each sample was expressed as a ratio of cell counts at
the wound edge and the adjacent (control) area and then averaged. Counts
were performed on sections from up to six separate explants. Cell counts for
BrdU-positive nuclei were performed in an identical manner, with the data ex-
pressed as BrdU-positive nuclei/total number of cells per microscopic ﬁeld
(400 mm 300 mm). The appearance of chondrocyte clusters at the wound
edge was quantiﬁed by manual counting cells within a 120,000 mm2 area
(600 mm 200 mm; height depth) at the wound edge.IMMUNOHISTOCHEMICAL AND IMMUNOFLUORESCENT
LABELLINGAll sections for immunostaining were deparaﬁnized and hydrated prior to
immunolabelling. Sections were unmasked using boiling Vector unmasking
solution (1:100) in distilled water for 1 min (Vectorlabs, UK; H-3300). To allow
identiﬁcation of proliferating chondrocytes, explants were incubated with
100 mM 5-bromo-2-deoxyuridine (BrdU) for 12 h prior end of culture period.Sections were pre-treated with 2 N hydrochloric acid for 1 h at 37C to dena-
ture DNA then incubated with borate buffer (0.1 M pH 8.0) to neutralise the
acid for 15 min. Sections that were immunolabelled with antibodies against
collagen VI were digested with hyaluronidase (1 mg/ml, 1 h at 37C;
Sigma-Aldrich) to remove proteoglycan and reveal the collagen ﬁbril epitope.
Immunolabelled antigen was visualised using peroxidase-based Vector SG
substrate kit following the manufacturers instructions. Fluorescence visual-
isation was used for sections incubated with primary antibodies against col-
lage type VI and Notch1. Sections were incubated overnight at 4C in
a humidity chamber with primary antibody, then washed with TBS/T and
then incubated with the appropriate ﬂuorescein isothiocyanate-conjugated
(FITC) secondary antibody for 1 h at room temperature. Sections were
then washed repeatedly in TBS/T and mounted in Vectashield (Vectorlabs)
with propidium iodide to counterstain nuclei. Immunoﬂuorescent labelling
was examined using Olympus BX61 ﬂuorescence microscope.TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE dUTP NICK
END LABELLING (TUNEL) TO DETECT DNA FRAGMENTATION
IN APOPTOTIC NUCLEIEight micron paraformaldehyde ﬁxed sections were dewaxed, rehydrated
then washed in TBS. Sections were then incubated in the presence of
20 mg/ml proteinase K for 20 min at room temperature then equilibriated in
terminal deoxynucleotidyl transferase (TdT) buffer (FragEL kit; Calbiochem)
prior to incubation with TdT labelling mix containing ﬂuorescein-conjugated
deoxynucleotides for 90 min at 37C. Sections were washed repeatedly in
TBS and then mounted in Vectashield containing propidium iodide. Sections
were viewed using the Leica TCS SPE confocal system.REAL-TIME PCR AMPLIFICATION AND QUANTITATIVE
ANALYSISQuantitative polymerase chain reaction (qPCR) using the ﬂuorescent dye
SYBR Green (Primer Design, UK) was used to determine the absolute ex-
pression levels of metalloproteinase-13 (MMP13), ADAMTS4 (a disintegrin
Fig. 5. RT-QPCR analysis of untreated control and FGF2 stimulated explants. Explants were cultured for 21 days in the presence or absence
of FGF2 (100 ng/ml) then processed for RNA isolation and cDNA synthesis. QPCR analysis of Notch1, HES1, MMP13 and ADAMTS4 abso-
lute gene expression levels as a ratio of 18S expression was performed and results shown graphically above (n¼ 4; P< 0.05 for signiﬁcance).
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hancer of Split-1 (HES1) between FGF2 treated and untreated explants.
The PCR products from reactions containing the following primer pairs;
MMP13 (forward: TGG TGA TGA AAC CTG GAC AA, reverse: GGC GTT
TTG GGA TGT TTA GA), Notch1 (forward: TGA GCA CGC GGG CAA
GTG CAT, reverse: TGC AGA CAC TGG CAC TCG A), HES1 (forward:
GCC TCC ACC TAA ACG ACT CA, reverse: TTG ATC CCC CTC GCT
CTT TTA) and 18S rRNA primers were cloned and sequenced to conﬁrm
their identities. Real-time PCR reactions were carried out in 25 ml volumes
in a 96-well plate containing 3.5 mM MgCl2, 200 mM dNTPs, 0.3 mM of sense
and antisense primers, 0.025 U/ml enzyme and 1:66000 SYBR Green1. Ab-
solute values for the gene of interest were calculated from standard curves
generated using serially diluted plasmid cloned and sequence veriﬁed tem-
plate and were normalized to the housekeeping gene 18S rRNA.STATISTICAL ANALYSESThe data are reported as mean  standard deviation of the indicated
number of experimental values. All datasets were assessed for normal pop-
ulation distribution using the ShapiroeWilk test, and homogeneity of variance
using Levine’s test. One-way analysis of variance (ANOVA) was used to
compare means of datasets that met the assumptions of this test, followed
by post-hoc pair-wise comparisons using the Bonferroni correction. For
two-sample comparisons we used unpaired Student’s t-test.ResultsFGF2 STIMULATES CHONDROCYTE PROLIFERATION IN
WOUNDED ARTICULAR CARTILAGEArticular cartilage from the medial aspect of the medial
groove of the metacarpalphalangeal joint of immature bo-
vine steers was wounded in situ, using a 6 mm biopsy
punch. The wounded cartilage was immediately removed
from the joint and placed in culture medium either in the
presence or absence of FGF2 (1e100 ng/ml) for 10.5 or
21 days. From histologic analysis of haemotoxylin and eo-
sin stained tissue sections we observed increased celldensity at the wound edges, which was most pronounced
in explants that had been treated with 100 ng/ml FGF2,
[Fig. 1(A)]. The cellular density of FGF2 stimulated and un-
stimulated explants at the wound margin at 10.5 and 21
days was determined through cell counts and expressed
as a ratio of the cellular density per unit area at the wound
margin compared to a directly adjacent area on the same
section, [Fig. 1(B)]. The ratio of cell density at the wound
edge was signiﬁcantly increased when comparing tissue
sections from similarly treated explants taken from 10.5 to
21 day incubations (P< 0.05). After 10.5 days statistical dif-
ferences in cell ratios were detected between control un-
treated explants and explants grown with 1 ng/ml FGF2
compared to explants grown with 100 ng/ml FGF2
(1.08 0.09 and 1.09 0.05 vs 1.22 0.08; n¼ 6;
P< 0.05; respectively). The latter differences were main-
tained in 21 day samples where explants that were treated
with 100 ng/ml FGF2 showed signiﬁcant increases in cell
ratios when compared to control untreated explants and ex-
plants treated with 1 ng/ml FGF2 (2.23 0.31 vs
1.43 0.18 and 1.50 0.14; n¼ 6; P< 0.05, respectively).
Proliferation was attributed to the action of exogenous
added FGF2, as the addition of the potent FGF receptor
(FGFR) inhibitor PD173074 did not provoke a signiﬁcant
increase in cell ratio in wounded in FGF2 treated explant
cultures, [Fig. 1(C)].CELLULAR PROLIFERATION MANIFESTS ITSELF AS
CHONDROCYTE CLUSTER FORMATIONThe most obvious morphological feature of chondrocytes
in FGF2 stimulated wound edges was the appearance of
chondrocyte clusters. We performed another series of cell
counts within a ﬁxed area of the wound margin to quantify
Fig. 6. The effect of g-secretase inhibitor DAPT on FGF2 induced cellular proliferation in wounded cartilage explants. Wounded
explants were incubated in culture medium containing, DMSO, DMSO plus DAPT 100 mm, 100 ng/ml FGF2 plus DMSO and FGF2 plus
DAPT for 21 days. The culture medium was replenished thrice weekly. Haemotoxylin and eosin stained sections (A) from FGF2-DAPT treated
explants (right) show no apparent decrease in chondrocyte cluster formation compared the control cultures incubated with FGF2-DMSO (left).
Quantitative cell count analysis as expressed as a ratio of cell density of wounded region vs adjacent control region explants (n¼ 4; P< 0.05
for signiﬁcance) (B).
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noted two major differences, ﬁrstly that the appearance of
ﬁve or more chondrocytes within a single lacunae was re-
stricted to explants that had been stimulated with 10 ng/ml
or 100 ng/ml FGF2, and that secondly that there were in-
creases in the number of three or four chondrocytes per la-
cunae in FGF2 stimulated chondrocytes compared to
unstimulated explants, [Fig. 2(A)]. To test whether chondro-
cyte clustering was caused by migration or cell division, ex-
plants were incubated for 12 h in 10 mM BrdU on the day 20
of culture. Bromodeoxyuridine incorporation in chondro-
cytes was detected using antibody labelling, [Fig. 2(B)].
We observed BrdU-positive cells within chondrocyte clus-
ters and to a greater extent in FGF2 stimulated explants
compared to unstimulated explants. Cell count ratios of
BrdU-positive cells vs total number of cells per unit area
showed that FGF2 treated explants had on average 5-fold
more labelled nuclei at their wound edges than the adjacent
control regions or untreated wound edges (0.076 0.03 vs
0.014 0.007 and 0.016 0.006; n¼ 3; P< 0.05, respec-
tively), [Fig. 2(C)]. We observed no BrdU labelling in nuclei
within the control regions of untreated explants.IMMUNODETECTION OF COLLAGEN TYPE VI AND NOTCH IN
FGF2 STIMULATED CHONDROCYTESWe analysed whether chondrocytes in a cluster conﬁgu-
ration within FGF2 stimulated wounded explants were part
of a large single chondrone or had separated following
cell division to generate individual chondron units. Following
immunolabelling for collagen type VI, a marker for thepericellular domain of chondrocytes, we observed that indi-
vidual chondrocytes within a single lacunae produced an in-
tensely labelled pericellular matrix, [Fig. 3(A) and (C)].
Immunolabelling of chondrocyte clusters in bovine OA car-
tilage with antibodies against collagen type VI also gener-
ated a similar labelling proﬁle, [Fig. 3(B) and (D)]. We
used antibody bTan20 (anti-Notch1) to immunolabel tissue
sections, Fig. 4. Positive labelling was detected in chondro-
cytes within the wound margin of FGF2 stimulated explants,
[Fig. 4(B)]. Very feint or no labelling for bTan20 was de-
tected in chondrocytes in the wound margins of unstimu-
lated explant, [Fig. 4(A)]. QPCR analysis of gene
expression in FGF2 treated explants showed that the levels
of Notch1 (2.6-fold) and HES1 (3.2-fold) were increased
compared to untreated controls, Fig. 5. Additionally, we ob-
served that MMP13 metalloproteinase (7.8-fold) and
ADAMTS4 aggrecanase (3.4-fold) gene activity was also
signiﬁcantly increased in FGF2 explants compared to
controls.MODULATING NOTCH SIGNALLING IN FGF2 STIMULATED
WOUNDED ARTICULAR CARTILAGEWe analysed whether downstream canonical Notch sig-
nalling through ligand binding and generation of a N-termi-
nal intracellular domain (NICD) through the action of
g-secretase mediated cleavage inﬂuences the mitogenic
effect of FGF2 stimulation. Notch signalling was blocked
through culture of FGF2 stimulated wounded cartilage
explants for 21 days with DAPT, which inhibits g-secretase
activity. We observed no reduction in chondrocyte cluster
Fig. 7. The effect of sJ1 binding on FGF2 induced chondrocyte proliferation in wounded cartilage explants. Wounded cartilage explants were
cultured in the presence or absence of sJ1 ligand, and with or without 100 ng/ml FGF2 present in the culture medium. A graph of the cell
density at the wound edge expressed as a ratio of cell counts from a ﬁxed area at the wound margin compared to an adjacent area of cartilage
showed that co-incubation with sJ1 blocked FGF2 induced cellular proliferation in wounded explants (A). Haemotoxylin and eosin stained tis-
sue sections show that chondrocyte cluster formation (arrowheads) occurs in control and FGF2 treated explants, however no cluster formation
is present in sJ1 or sJ1-FGF2 explants (B). Evidence of pyknosis (shrinking nuclei and cytoplasm) was evident in sJ1 and sJ1-FGF2 treated
tissue sections (arrow). Bar equals 50 mm.
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[Fig. 6(A)]. Explants cultured in FGF2-DMSO had a cell
count ratio (wounded/control regions) of 1.84 0.19
(n¼ 6), and explants cultured in FGF2-DAPT had an aver-
age ratio of 1.79 0.35 (n¼ 6), and both ratios weresigniﬁcantly higher than for those in explants treated with
DMSO or DAPT alone (1.21 0.13 and 1.27 0.11;
n¼ 4; P< 0.05) [Fig. 6(B)].
Recombinant soluble Jagged1 ligand (sJ1) has been
reported to stimulate Notch signalling21. We utilised sJ1 to
Fig. 8. Detection of DNA fragmentation in sJ1 treated explants using the TUNEL assay. Wounded cartilage explants were ﬁxed, wax embed-
ded, sectioned and then subjected to TUNEL analysis (A). Positively labelled (green) nuclei and apoptotic bodies were apparent at low fre-
quencies at the wound margin in control and FGF2 treated sections, in contrast, many more nuclei labelled positively for DNA fragmentation in
sJ1 and FGF2-sJ1 treated explants. White arrows denote the wound margin of the explants. Bar equals 50 mm. Quantiﬁcation of apoptotic
nuclei, expressed as number of apoptotic cells divided by the total number of cells per unit area (400 mm 300 mm; n¼ 4, P< 0.05 for
signiﬁcance) (B).
216 I. M. Khan et al.: FGF2 induces chondrocyte clusters in situexamine the effect of ligand activated Notch1 signalling on
cellular proliferation in FGF2 stimulated and unstimulated
wounded cartilage explants, Fig. 6. Ratios of cells counts
from the wounded and adjacent control regions showed that
there was a statistically signiﬁcant decrease in the ratiobetween sJ1-FGF2 treated explants compared to FGF2-
only stimulated explants (0.98 0.16 vs 1.81 0.46; n¼ 6;
P< 0.05, respectively), [Fig. 7(A)]. During histologic analysis
of haemotoxylin and eosin stained tissue sections from
sJ1-only or sJ1-FGF2 wounded explants we noted the
217Osteoarthritis and Cartilage Vol. 18, No. 2appearance of pyknosis in some cells at the lateral margin of
thewound, [Fig. 7(B)] (sJ1-FGF2,arrowed ). Thecytoplasmof
cells that were pyknotic also stained intensely for eosin
(data not shown).SJ1 INDUCES APOPTOSIS IN CHONDROCYTES AT THEWOUND
EDGETo conﬁrm the histological appearance of apoptotic nuclei
at the wound edge in sJ1 treated explants we used the
TUNEL assay, to detect DNA fragmentation that character-
istically occurs late in apoptosis, [Fig. 8(A)]. In control and
FGF2 treated explants few nuclei were labelled positively
for DNA fragmentation, however, in sJ1 or FGF2-sJ1
treated explants many more cells exhibited positive label-
ling for fragmentation. Apoptotic nuclei were quantiﬁed (ra-
tio of apoptotic cells and total cell number within a deﬁned
area) at the wound edge in control untreated, FGF2, sJ1
and FGF2-sJ1 treated explants, [Fig. 8(B)]. There were
ﬁve- and seven-fold more apoptotic nuclei vs normal cells
per unit area in FGF2-sJ1 treated explants than in control
untreated or FGF2 explants (0.28 0.15 vs 0.052 0.02
or 0.04 0.01, respectively; n¼ 4, P< 0.05). There was
no statistical difference in numbers of apoptotic nuclei be-
tween explants treated with sJ1 and FGF2-sJ1 (P¼ 0.068).Discussion
Chondrocyte clonal cluster formation is a morphological
and histopathological feature of OA. Whether cluster forma-
tion is an attempt to repopulate the matrix or reversion to an
earlier developmental phase has not been determined.
There is good evidence to suggest that FGF2 stimulates
cluster formation; in a genetic screen to isolate factors
that induce chondrocyte cluster formation in agarose,
FGF2 was isolated in addition to six other genes that
when transfected back into chondrocytes all induced
FGF2 expression22. That FGF2 has a mitogenic effect on
articular chondrocytes has been known for many years5,
and also that FGF2 injected intra-articularly into joints that
have experimentally produced intrachondral lesions results
in cellular proliferation and regeneration23. The effect of
FGF2 on mechanically impacted cartilage causes cellular
proliferation on the surface of the tissue from cells that
are thought to migrate from within the damaged cartilage24.
We also observed a proliferative response in our experi-
mental model that was limited to within 200e300 mm of
the wound edge. Previous studies have shown that follow-
ing wounding, chondrocytes that lie near the wound margin
die through a combination of necrosis and apoptosis, pro-
teoglycan loss at the margin, and, collagen denaturation in-
dicative of enzymatic cleavage of ﬁbres is also present13.
The initial mechanical trauma and subsequent catabolic
response is thought to cause swelling and distension in
the pericellular microenvironment (chondron) in surviving
chondrocytes adjacent to the wound edge25. Enzymatic dis-
ruption of collagen type II and IX localisation is linked to the
initiation of cellular division to occupy the expanding micro-
envoirment25. Our data conﬁrms, from the perspective of
gene expression, that remodelling of the extracellular matrix
is occurring through the increased expression of MMP13
and ADAMTS4 in FGF2 stimulated explant cultures. We
observed that the intrinsic repair response of wounded artic-
ular cartilage was accelerated using exogenously applied
FGF2 such that chondrocyte cluster formation, was in-
duced. The instrinsic response in the absence ofexogenously applied FGF2 was still proliferation, however,
it occurred at a much slower rate. A previous study has
demonstrated that the mean doubling time of surviving
chondrocytes in freeze-thawed osteochondral cartilage
cores that are reimplanted in vivo is approximately 150
days, the same study showed that in vivo, chondrocytes
within clusters do not divide exponentially and that cell cy-
cling is not synchronised26. In our model, the presence of
foetal calf serum and FGF2 that was continually replenished
was probably a large factor in reducing the mean doubling
time to approximately 5 days, and, we too saw evidence
of unsynchronised cell division, in that BrdU labelling of
cells in clusters was variable. Therefore the wounded
explant culture model we have described provides a repro-
ducible in vitro method to study chondrocyte cluster forma-
tion. In addition it may also be a sensitive assay for
chondron disruption, as hyperproliferation in the cluster
conﬁguration was not noted in cartilage adjacent to the
wound site. Cellular migration has been hypothesised to
be a factor in chondrocyte cluster formation due to the
fact that the cellular density in OA areas is similar to that
in unaffected areas27. Whilst it is not possible yet to study
migration of chondrocytes within the explants we did note
that chondrocyte clusters appeared to coalesce to form ir-
regularly shaped cell masses near the wound edge.
Whether these cluster then reorientate and consolidate is
arguable, although some form of polarity in the shape of in-
ward facing primary cilium of chondrocytes within clusters in
OA cartilage has been recently described28.
We also observed labelling for Notch1 in FGF2 induced
chondrocyte clusters and isolated cells at the wound mar-
gin, that was either much weaker or absent at the 21 day
time point in non-treated explants. Notch1 is upregulated
during osteoarthritis, where it has been shown to be immu-
nolocalised to clusters of proliferating cells18,19. The prolifer-
ating cells in another model of experimental wounding,
through impact injury, also express Notch1 though the cells
did not adopt a cluster conﬁguration24. The current ideas re-
garding Notch signalling in OA cartilage suggest that prolif-
erating cells adopt a dedifferentiated phenotype, that
resembles characteristics of mesenchymal stem/progenitor
cells, and that Notch signalling maintains this prechondro-
genic status19,29,30. We sought to test the role of Notch1
expression during chondrocyte cluster formation through
co-incubation of FGF2 stimulated explants with an inhibitor
or activator of Notch signalling. Notch receptors and their
ligands are components of an evolutionary conserved
signalling pathway that regulates a plethora of cellular and
intercellular functions including, proliferation, differentiation
and survival in a cellular and developmental speciﬁc con-
textual manner31. Activation of canonical Notch signalling
requires that membrane bound ligand interact in a juxtacrine
manner with Notch receptors on an adjacent cell32. DAPT
blocks Notch receptor activation through inhibition of intra-
membranous proteolysis of ligand activated Notch receptor,
and therefore, generation of the Notch intracellular domain
transcriptional activator. When g-secretase-dependent
Notch signalling was blocked in Notch1 expressing cells
by DAPT in FGF2 treated wounded explants, cellular prolif-
eration was unaffected. This ﬁnding necessarily excludes
cellecell juxtacrine Notch signalling in chondrocytes as be-
ing a factor in cellular proliferation at the wound edge. As
the reported non-canonical pathways of Notch activation
that involve ligand-independent endosomal trafﬁcking of
full-length receptors are also thought to be g-secretase sen-
sitive33, we assume that these mechanisms are also not ac-
tive in Notch1 expressing chondrocytes at the wound edge,
218 I. M. Khan et al.: FGF2 induces chondrocyte clusters in situalthough, g-secretase insensitive activation pathways may
exist. sJ1 is a synthetic, disulphide-linked homodimeric pro-
tein that has been shown to activate Notch signalling in
C2C12 cells such that it inhibits myogenesis21. Addition of
sJ1 has a profound affect on Notch1 expressing cells at
the wound edge of FGF2 wounded explants, causing a total
block in cellular proliferation primarily through the induction
of apoptosis. The latter ﬁnding begs the question; is Notch1
receptor-induced apoptosis in chondrocytes at the wound
edge physiologically relevant? Soluble Notch ligands have
been described previously in other tissues; for example,
SJ1, product of an alternatively spliced transcript that gen-
erates a protein missing transmembrane and intracellular
portions of the protein, is expressed by suprasbasal cells
in skin epithelium and induces keratinocyte differentiation
in in vitro assays34. Also, it has been shown that during
pre-cancerous transdifferentiation of pancreatic acinar-to-
ductal metaplasia, aberrantly high levels of metalloprotei-
nase-7 (MMP7) induce ligand-independent Notch
signalling35,36. Co-incidentally, pro-MMP7 is expressed at
comparatively much higher levels by chondrocytes in the
surface and transitional zones and in chondrocyte clusters
of OA cartilage37,38. Therefore, potential mechanisms to
elicit non-juxtacrine and ligand-dependent or ligand-inde-
pendent Notch signalling are available, in the latter example
actually in diseased cartilage. Also, increased Notch1 ex-
pression and cell death are evident throughout the progres-
sion of osteoarthritis18,39. Therefore, we speculate Notch1
may act in a context-dependent manner to promote tissue
repair through ligand-independent mechanisms, however,
aberrant activation of Notch signalling pathways during os-
teoarthritis has the potential to induce apoptosis of chondro-
cytes causing further degenerative changes.
In summary, our work describes chondrocyte cluster for-
mation in situ, in experimentally wounded, FGF2 stimulated
articular cartilage explants. We have evidence to show that
modulating Notch signalling blocks a proliferative response
in chondrocytes at the wound edge through apoptosis. How
this mechanism relates to physiological function and disease
is as yet undetermined and is the subject of further study.Conﬂict of interest
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